Skip to main content

Day: August 30, 2021

Simply Better Brands Corp. Announces Second Quarter 2021 Results

VANCOUVER, British Columbia, Aug. 30, 2021 (GLOBE NEWSWIRE) — Simply Better Brands Corp. (“SBBC” or the “Company“) (TSX Venture: SBBC) announces its financial results for the quarter ended June 30, 2021. All amounts are expressed in United States dollars unless otherwise noted. Certain metrics, including those expressed on an adjusted basis, are non-IFRS measures, see “Non-IFRS Measures” below. Corporate Developments Purekana, LLC (“Purekana”), a subsidiary of the Company, entered into a partnership with Chemesis International Inc. (“Chemesis”) – On April 13, 2021, Purekana entered into a brand partnership with Chemesis, a leading cannabis and CBD retailer, under which Purekana’s industry-leading CBD products will become available at hundreds of proprietary Chemesis...

Continue reading

Gildan Publishes its 17th Environmental, Social, and Governance (ESG) Report

MONTREAL, Aug. 30, 2021 (GLOBE NEWSWIRE) — Gildan Activewear Inc. (GIL: TSX and NYSE) is pleased to share the publication of its 17th Environmental, Social, and Governance (ESG) report, available here. The 2020 ESG report showcases Gildan’s approach and commitment to ESG, the Company’s 2020 performance results, and key priorities towards continuing its vision of Making Apparel Better®. In 2020, the Company faced unprecedented circumstances due to the impacts of the COVID-19 pandemic and two back-to-back hurricanes in Central America. Still, despite these challenging events, Gildan ended the year on a strong note, demonstrating that operating and financial performance combined with a focus on ESG creates value for all stakeholders. “Last year, more than ever, we were able to witness the strength and resiliency of our unique business...

Continue reading

Synaptics to Acquire DSP Group, Expanding Leadership in Low Power AI Technology

Further Accelerates IoT Diversification While Strengthening Wireless Connectivity Portfolio SAN JOSE, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) — Synaptics Incorporated (Nasdaq: SYNA) and DSP Group, Inc. (Nasdaq: DSPG) today announced the signing of a definitive agreement, unanimously approved by the boards of directors of both companies, whereby Synaptics acquires DSP Group, a leading global provider of voice and wireless chipset solutions for converged communications, at $22.00 per share in an all-cash transaction. The combination is anticipated to generate annual run rate synergies of $30 million for the new entity to be realized within 12 months of closing and is immediately accretive to Synaptics’ non-GAAP earnings. The transaction is expected to be financed through a combination of cash on hand and a fully committed, incremental...

Continue reading

BrainsWay to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

BURLINGTON, Mass. and JERUSALEM, Aug. 30, 2021 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that Christopher von Jako, Ph.D., President and Chief Executive Officer, will present and participate in one-on-one investor meetings at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021. About BrainsWayBrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared...

Continue reading

EZ Exchange OU (EZ365) Acquired By Wee-Cig International Corporation, Russell Korus Named CEO and President

Acquisition Aims to Accelerate EZ365 Vision of Mass Adoption of Blockchain Technology, Expand Investor Base and Value LAS VEGAS, NV, Aug. 30, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Wee-Cig International Corporation (OTCMarkets: WCIG), a company focused on identifying and growing top tech companies in emerging markets, today announced that it has acquired a leading innovator in the blockchain space, EZ Exchange OU (“EZ Exchange”), an Estonian corporation that owns EZ365 and all of its affiliated divisions (EZ NFT, EZ Exchange, EZ Win and EZ Academy).  Recognizing the immense disruptive potential of the blockchain across different industries, Wee-Cig is excited to acquire an innovative and established blockchain-based ecosystem that enables users to invest, play, trade and learn in one integrated, user-friendly platform.  The...

Continue reading

Portage Biotech Announces Results for First Quarter of 2022 Fiscal Year

– $29 million raised during quarter with broad institutional support – Proceeds will accelerate advancement of clinical pipeline toward multiple data readouts over the next 18-24 months WESTPORT, Conn., Aug. 30, 2021 (GLOBE NEWSWIRE) — Portage Biotech Inc. (NASDAQ: PRTG) (“Portage” or the “Company”) a clinical-stage immuno-oncology company focused on the development of therapies and treatments targeting cancer treatment resistance, today announced financial results for the quarter ended June 30, 2021. “With the transformation of Portage now complete, our focus for the coming year is to significantly accelerate our clinical pipeline of novel immuno-oncology therapeutics designed to overcome cancer treatment resistance,” said Dr. Ian Walters, chief executive officer of Portage Biotech. “Our recent financings provide us...

Continue reading

Diffusion Pharmaceuticals Announces Clearance of IND Application for TSC by FDA’s Pulmonology, Allergy, and Critical Care Division

Phase 2 DLCO Trial in Interstitial Lung Disease Expected to Begin in Q4 Under New IND  Fourth FDA Division to Clear TSC IND   CHARLOTTESVILLE, Va., Aug. 30, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (Diffusion or the Company), an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, today announced that the Company has obtained clearance of its Investigational New Drug (IND) application submitted to the U.S. Food and Drug Administration’s (FDA) Pulmonology, Allergy, and Critical Care Division for the company’s lead product candidate, trans sodium crocetinate (TSC). Diffusion now has open INDs related to TSC with four FDA divisions– Pulmonology, Allergy, and Critical Care; Cardiology and Nephrology; Neurology;...

Continue reading

Auction result of Treasury Bills – RIKV 21 1015 – RIKV 22 0215

Series  RIKV 21 1015 RIKV 22 0215Settlement Date  09/01/2021 09/01/2021Total Amount Allocated (MM)  15,800 9,600All Bids Awarded At (Price / Simple interest)  99.808 / 1.574 99.104 / 1.949Total Number of Bids Received  19 12Total Amount of All Bids Received (MM)  43,700 10,600Total Number of Successful Bids  10 11Number of Bids Allocated in Full  10 11Lowest Price / Highest Simple Interest Allocated  99.808 / 1.574 99.104 / 1.949Highest Price / Lowest Simple Interest Allocated  99.860 / 1.147 99.218 / 1.699Lowest Price / Highest Simple Interest Allocated in Full  99.808 / 1.574 99.104 / 1.949Weighted Average of Successful Bids (Price/Simple Interest)  99.819 / 1.484 99.144 / 1.861Best Bid (Price / Simple Interest)  99.860 / 1.147 99.218 / 1.699Worst Bid (Price / Simple Interest)  99.775 / 1.845 99.081 / 1.999Weighted...

Continue reading

ParcelPal Logistics Inc. Reports Second Quarter 2021 Results Highlighted by a 268% Increase in Gross Margin Coupled with a 45% decrease in Net Loss

VANCOUVER, British Columbia, Aug. 30, 2021 (GLOBE NEWSWIRE) — ParcelPal Logistics Inc. (“ParcelPal” or the “Company”), (OTC:PTNYF) (CSE:PKG) (FSE:PT0) is pleased to announce its Q2 2021 financial results highlighted by a 268% increase in gross margin and a 45% lower net loss compared to the same period 2020. Overview In Q2 2021, the Company continued its financial improvement, with revenue of approximately $1.32 million. Most notable is that our gross margin had a 268% increase from 3.5% in Q2 2020 to 12.7% in Q2 2021. Additionally, the Company’s net loss decreased 45% to $454,722 (compared to $824,551 in Q2 2020). Continued diversification of our customer base has continued to stabilize our revenue, driven by revenue out of the pharmaceutical, meal kit and retail spaces. The Company has also recently announced new agreements,...

Continue reading

Blueberries Medical Reports 2021 Q2 Financial Results and Provides Corporate and Operations Update

TORONTO, Aug. 30, 2021 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “Company” or “Blueberries“), is pleased to report its financial results for the quarter ended June 30, 2021. Today, Blueberries has filed its unaudited condensed interim consolidated financial statements and related management’s discussion and analysis, both of which are available on Blueberries’ profile at www.sedar.com. Blueberries Medical Corp. continues deploying the strategy of reducing administrative cost, capital and operational expenditures, as well as focusing on multiple revenue generating activities. Also, people...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.